Merit Medical Systems Inc. has appointed Sheri Lewis as Executive Vice President of Global Operations, effective August 31, 2026, following the resignation of Neil W. Peterson. Her Leadership is expected to enhance operational excellence, crucial for the company’s growth strategy.
Key Highlights
- Sheri Lewis will serve as Executive Vice President of Global Operations starting August 31, 2026.
- Neil W. Peterson's role as Chief Operating Officer has been eliminated; he will transition to a Senior Advisor role until March 5, 2027.
- Lewis's Employment Agreement includes a base salary of $600,000, a $400,000 signing bonus, and a target Bonus of 60% for the 2026 fiscal year.
Merit Medical Systems Inc. (NASDAQ: MMSI) has made significant leadership changes as part of a reorganization of its global operations function. The company has eliminated the Chief Operating Officer position, resulting in Neil W. Peterson transitioning to a Senior Advisor role. Peterson will remain until March 5, 2027, ensuring a smooth transition during this key period.
This restructuring reflects Merit Medical's intent to streamline its operations, which may enhance decision-making at the leadership level, ultimately impacting operational efficiency.
Leadership Transition Details
Effective August 31, 2026, Sheri Lewis has been appointed as the Executive Vice President of Global Operations. With three decades of experience in global operations and Supply chain management, Lewis's previous roles include Chief Supply Chain and Operations Officer at Skin Health Systems and Executive Vice President at Avantor Sciences. This appointment places Lewis in a key position where her extensive experience with large organizations will be leveraged to drive operational excellence.
The decision to appoint a new executive reflects Merit Medical's commitment to strengthening its operations, vital as the company pursues its Long-term Growth framework.
Employment Agreement Features
As part of her new role, Lewis has signed an Employment Agreement with a base salary of $600,000 annually, alongside a signing bonus of $400,000. For the 2026 fiscal year, she is set to participate in Merit’s bonus program with a target bonus representing 60% of her base salary. The agreement stipulates a maximum bonus potential of 200%.
The package is designed to incentivize high performance, aligning her interests with those of the company and its stakeholders. Investors may view this compensation structure positively, as it typically encourages executives to focus on company growth and profitability.
Impact of Leadership Change
The leadership transformation signals Merit's strategic intent to refine its global operational strategies. Peterson's departure comes after over 32 years of service at Merit, where he has made significant contributions to operational efficiencies and product quality. His exit and transition to an advisory role may bring about continuity in operations while paving the way for Lewis to implement new strategies.
This shift could enhance the company’s ability to adapt to industry challenges, such as supply chain dynamics and changing regulations, which could ultimately benefit Stakeholders looking for sustained performance.
Upcoming Catalysts to Monitor
Investors should monitor developments leading up to Peterson’s complete departure on March 5, 2027, as his insights and experience will still play a important role in transitioning responsibilities to Lewis. The upcoming months may reveal further strategic initiatives from Lewis as she acclimates to her new position. Merit Medical’s performance in the 2026 fiscal year under Lewis’s operational leadership will be key, making it essential to watch how her actions translate into results in the upcoming quarterly reports.
Peers Moving on This News
- MiniMed Group, Inc. (NASDAQ: MMED) down 5.0%
- Haemonetics Corp (NYSE: HAE) down 0.2%
- ICU Medical, Inc. (NASDAQ: ICUI) little changed



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...